Literature DB >> 15983315

Impact of overweight on chronic microvascular complications in type 1 diabetic patients.

Christophe E M De Block1, Ivo H De Leeuw, Luc F Van Gaal.   

Abstract

OBJECTIVE: To investigate a possible association of BMI with retinopathy and neuropathy in type 1 diabetes. Retinopathy and neuropathy may not only be related to glycemic control and diabetes duration but also to blood pressure and BMI. RESEARCH DESIGN AND METHODS: A total of 592 type 1 diabetic patients without nephropathy were studied (M/F: 324/268; age: 41 +/- 12 years; duration: 19 +/- 11 years; HbA(1c) [A1C]: 7.9 +/- 1.1%). Patients were subdivided according to BMI: 168 men and 146 women with BMI <25 kg/m(2), and 156 men and 122 women with BMI > or =25 kg/m(2). Retinopathy was examined by fundoscopy and neuropathy by electromyography.
RESULTS: Hypertension (>130/85 mmHg) was present in 40%, retinopathy in 53%, and neuropathy in 43% of patients. Overweight subjects had more retinopathy (63 vs. 45%, P < 0.0001, odds ratio [OR] = 2.1) and neuropathy (49 vs. 38%, P = 0.008, OR = 1.6) than normal-weight patients. Patients with retinopathy were older (45 +/- 12 vs. 37 +/- 11 years, P < 0.0001) and had a longer diabetes duration (25 +/- 10 vs. 12 +/- 8 years, P < 0.0001), a higher A1C (8.0 +/- 1.1 vs. 7.7 +/- 1.1%, P = 0.001), and a higher BMI (25.8 +/- 4.1 vs. 24.7 +/- 4.2 kg/m(2), P = 0.001) than individuals without retinopathy. The same results are found in neuropathy. Logistic regression analysis showed that diabetes duration (beta = 0.15, P < 0.0001), blood pressure (beta = 0.22, P = 0.0047), and A1C (beta = 0.24, P = 0.01), but not BMI, lipid levels, sex, or age, were independent risk factors for retinopathy. Likewise, duration (beta = 0.05, P < 0.0001), age (beta = 0.04, P = 0.0001), A1C (beta = 0.35, P < 0.0001), and sex (beta = 0.74, P = 0.0001) but not BMI, lipid levels, or hypertension were independently associated with neuropathy. Men had more neuropathy than women (50 vs. 34%, P < 0.0001, OR = 1.9). Leptin and adiponectin levels did not differ between individuals with or without microvascular complications.
CONCLUSIONS: Retinopathy and neuropathy are more prevalent in overweight (BMI > or =25 kg/m(2)) type 1 diabetic subjects. However, logistic regression analysis showed that diabetes duration and A1C remain the main determinants for retinopathy and neuropathy.

Entities:  

Mesh:

Year:  2005        PMID: 15983315     DOI: 10.2337/diacare.28.7.1649

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  31 in total

1.  Temporal patterns in overweight and obesity in Type 1 diabetes.

Authors:  B Conway; R G Miller; T Costacou; L Fried; S Kelsey; R W Evans; T J Orchard
Journal:  Diabet Med       Date:  2010-04       Impact factor: 4.359

Review 2.  Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

Authors:  Anna Grisold; Brian C Callaghan; Eva L Feldman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-04       Impact factor: 3.243

3.  Association of pre-pregnancy BMI and postpartum weight retention with postpartum HbA1c among women with Type 1 diabetes.

Authors:  T Huang; F M Brown; A Curran; T James-Todd
Journal:  Diabet Med       Date:  2014-11-19       Impact factor: 4.359

Review 4.  Diabetic neuropathy: clinical manifestations and current treatments.

Authors:  Brian C Callaghan; Hsinlin T Cheng; Catherine L Stables; Andrea L Smith; Eva L Feldman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

5.  Serial anthropometry predicts peripheral nerve dysfunction in a community cohort.

Authors:  Kelly R Ylitalo; William H Herman; Siobán D Harlow
Journal:  Diabetes Metab Res Rev       Date:  2013-02       Impact factor: 4.876

6.  Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status.

Authors:  Brian C Callaghan; Rong Xia; Mousumi Banerjee; Nathalie de Rekeneire; Tamara B Harris; Anne B Newman; Suzanne Satterfield; Ann V Schwartz; Aaron I Vinik; Eva L Feldman; Elsa S Strotmeyer
Journal:  Diabetes Care       Date:  2016-03-10       Impact factor: 19.112

7.  Laparoscopic Sleeve Gastrectomy for the Management of Type 1 Diabetes Mellitus.

Authors:  Salman Al Sabah; Eliana Al Haddad; Talal H Muzaffar; Ahmad Almulla
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

Review 8.  Role of adipocytokines in predicting the development of diabetes and its late complications.

Authors:  Nese Ersoz Gulcelik; Aydan Usman; Alper Gürlek
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

Review 9.  The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.

Authors:  Brian Callaghan; Eva Feldman
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

10.  Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.

Authors:  Melissa M Hamilton; Gordon A Byrnes; Jason G Gall; Douglas E Brough; C Richter King; Lisa L Wei
Journal:  Mol Vis       Date:  2008-12-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.